Gwenn Hansen Nurix Therapeutics, Inc. (NRIX) insider trading activity

NRIX Quotes by TradingView

Gwenn Hansen is Chief Scientific Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 50,670 shares of NRIX, which is worth approximately $991,611. The most recent transaction as insider was on Mar 01, 2021, when has been sold 800 shares (Common Stock) at a price of $35.95 per share, resulting in proceeds of $28,760. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.7K
12.23% 3M change
51.12% 12M change
Total Value Held $991,611

Gwenn Hansen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2021
SELL
Open market or private sale
$28,760 $35.95 p/Share
800 Reduced 5.48%
13,804 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
$5,808 $7.26 p/Share
800 Added 5.19%
14,604 Common Stock
Feb 18 2021
SELL
Open market or private sale
$29,392 $36.74 p/Share
800 Reduced 6.25%
12,000 Common Stock
Feb 18 2021
BUY
Exercise of conversion of derivative security
$5,808 $7.26 p/Share
800 Added 5.88%
12,800 Common Stock
Nov 30 2020
BUY
Exercise of conversion of derivative security
$10,080 $0.84 p/Share
12,000 Added 50.0%
12,000 Common Stock
GH

Gwenn Hansen

Chief Scientific Officer
San Francisco, CA

Track Institutional and Insider Activities on NRIX

Follow Nurix Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

News

Receive news related to Nurix Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NRIX